A new device aiming to offer continuous, personalized insight into gut health and hydration has just secured a significant financial boost. Throne Science, the company behind the tracking technology, announced it has raised $10.0M in a Series A round.
The funding, backed by a syndicate of investors including Will Ventures, Emerson Collective, and Felix Capital, will propel Throne Science toward its ambitious goal: developing the world’s first continuous tracking device for proactive insight into colorectal, urological, and prostate cancer.


















